Viatris (VTRS) Long-Term Debt Issuances (2019 - 2023)
Viatris (VTRS) posted quarterly Long-Term Debt Issuances of $300000.0 for Q4 2023, up 200.0% year-over-year from $100000.0 in Q4 2022, and up 200.0% quarter-over-quarter from $100000.0 in Q4 2022.
Viatris (VTRS) Long-Term Debt Issuances (2019 - 2023) Analysis & Trends
Viatris' Long-Term Debt Issuances history runs 5 years deep, the most recent figure standing at $300000.0 for Q4 2023.
- In Q4 2023, Long-Term Debt Issuances rose 200.0% year-over-year to $300000.0; the TTM figure through Dec 2023 stood at $300000.0 (down 99.98% YoY), while the FY2023 annual figure was $300000.0, down 99.98% from the prior year.
- Long-Term Debt Issuances for Q4 2023 stood at $300000.0, up from $100000.0 in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $11.4 billion in Q2 2020, with the low at $100000.0 in Q1 2022.
- The 5-year median for Long-Term Debt Issuances is $795.3 million (2022), against an average of $1.5 billion.
- The sharpest annual moves came in 2020 and 2021: Long-Term Debt Issuances soared 12739.19% in 2020, then tumbled 92.1% in 2021.
- Viatris' Long-Term Debt Issuances stood at $7.4 million in 2019, then jumped by 12739.19% to $950.1 million in 2020, then dropped by 14.75% to $810.0 million in 2021, then tumbled by 99.99% to $100000.0 in 2022, then surged by 200.0% to $300000.0 in 2023.
- Business Quant data shows VTRS's Long-Term Debt Issuances at $300000.0 in Q4 2023, $100000.0 in Q4 2022, and $1.1 billion in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 300,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 1.08 Bn |
| Sep 30, 2022 | 1.08 Bn |
| Jun 30, 2022 | 795.30 Mn |
| Jun 30, 2022 | 795.30 Mn |
| Mar 31, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Sep 30, 2021 | 810.00 Mn |
| Sep 30, 2021 | 810.00 Mn |
| Jun 30, 2021 | 900.10 Mn |
| Jun 30, 2021 | 900.10 Mn |
| Dec 31, 2020 | 950.10 Mn |
| Dec 31, 2020 | 950.10 Mn |
| Jun 28, 2020 | 11.40 Bn |
| Jun 28, 2020 | 11.40 Bn |
| Mar 31, 2020 | 33.10 Mn |
| Mar 31, 2020 | 33.10 Mn |